Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Keywords:
Grouped Articles
J&J’s Earnings Jump on Higher Drug Sales
Wall Street Journal 10/15/2014
J&J Leaves Crucell Deal Terms Open
Wall Street Journal 12/02/2010
J&J Said to Be in Deal Talks with Synthes
New York Times 04/16/2011
J&J in Talks to Buy Device Maker Synthes
Wall Street Journal 04/16/2011
Synthes Is Seen as a Fit for J&J
Wall Street Journal 04/18/2011
Grouped Articles
J&J Likely Gets Better Grade Than Deserved
Wall Street Journal 07/15/2013
Johnson & Johnson to Pay $2.2 Billion to Settle U.S. Probes
Wall Street Journal 11/05/2013
J&J Chief Tends Corporate Wounds
Wall Street Journal 08/30/2010
J&J Chief To Receive $143 Million Farewell
Wall Street Journal 03/15/2012
Sales of Johnson & Johnson's New Hepatitis C Drug Soar
Wall Street Journal 04/16/2014
J&J’s Earnings Jump on Higher Drug Sales
Wall Street Journal 10/15/2014
Grouped Articles
J&J Chief Tends Corporate Wounds
Wall Street Journal 08/30/2010
Sales of Johnson & Johnson's New Hepatitis C Drug Soar
Wall Street Journal 04/16/2014
J&J’s Earnings Jump on Higher Drug Sales
Wall Street Journal 10/15/2014
J&J’s Revenue Falls on Currency Woes
Wall Street Journal 01/27/2016
Wall Street Journal 01/25/2012
Wall Street Journal 02/22/2012
Grouped Articles
Sales of Johnson & Johnson's New Hepatitis C Drug Soar
Wall Street Journal 04/16/2014
J&J’s Earnings Jump on Higher Drug Sales
Wall Street Journal 10/15/2014
J&J Will Unveil New Drug Results
Wall Street Journal 11/11/2010
Grouped Articles
Sales of Johnson & Johnson's New Hepatitis C Drug Soar
Wall Street Journal 04/16/2014
J&J’s Earnings Jump on Higher Drug Sales
Wall Street Journal 10/15/2014
AbbVie Pins Hopes on Hepatitis C Treatment
Wall Street Journal 12/18/2014
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1